Margulis M S, Erukhimov E A, Andreiman L A, Viksna L M
Department of Experimental Surgery and Temporary Organ Substitution, Riga Medical Institute, Latvia, USSR.
Resuscitation. 1989 Oct;18(1):85-94. doi: 10.1016/0300-9572(89)90115-9.
The results of intensive therapy and temporary organ substitution by hemoperfusion through a suspension of active hepatocytes in 126 patients suffering from acute hepatic insufficiency (AHI) induced by virus B hepatitis, virus non-A, non-B hepatitis, acute toxic hepatitis, active liver cirrhosis, sepsis leptospirosis long-term subhepatic jaundice are presented in this paper. Hepatic encephalopathia confirmed both clinically and electroencephalographically was registered in all the patients. The patients were subdivided into two groups: a complex of commonly used curative measures according to the intensive therapy for AHI was applied in Group A (67 patients); in Group B (59 patients), alongside with the above measures, temporary organ substitution by hemoperfusion through a suspension of active porky hepatocytes was also performed. The lethality in Group A made up 59% and that in Group B was 37%.
本文介绍了对126例由乙型病毒性肝炎、非甲非乙型病毒性肝炎、急性中毒性肝炎、活动性肝硬化、败血症、钩端螺旋体病、长期肝下黄疸引起的急性肝功能不全(AHI)患者,采用强化治疗以及通过活性肝细胞悬液进行血液灌流的临时器官替代治疗的结果。所有患者均经临床和脑电图证实存在肝性脑病。患者被分为两组:A组(67例)采用根据AHI强化治疗常用的综合治疗措施;B组(59例)除上述措施外,还通过活性猪肝肝细胞悬液进行血液灌流的临时器官替代治疗。A组的死亡率为59%,B组为37%。